Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP, Karlsson K, Strömberg M, Jønsson V, Gill D, Hammerström J, Hertzberg M, McLennan R, Uggla B, Norman J, Wallvik J, Sundström G, Johansson H, Brandberg Y, Liliemark J, Juliusson G; Scandinavian and Australasian Leukaemia Lymphoma Groups (Allg). Mulligan SP, et al. Among authors: uggla b. Leuk Lymphoma. 2014 Dec;55(12):2769-77. doi: 10.3109/10428194.2014.893306. Epub 2014 Apr 16. Leuk Lymphoma. 2014. PMID: 24524339 Clinical Trial.
Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden.
Juliusson G, Abrahamsson J, Lazarevic V, Antunovic P, Derolf Å, Garelius H, Lehmann S, Myhr-Eriksson K, Möllgård L, Uggla B, Wahlin A, Wennström L, Höglund M; Swedish AML Group and the Swedish Childhood Leukemia Group. Juliusson G, et al. Among authors: uggla b. Leukemia. 2017 Mar;31(3):728-731. doi: 10.1038/leu.2016.312. Epub 2016 Oct 31. Leukemia. 2017. PMID: 27795559 Free PMC article. No abstract available.
Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
Lazarevic V, Hörstedt AS, Johansson B, Antunovic P, Billström R, Derolf Å, Lehmann S, Möllgård L, Peterson S, Stockelberg D, Uggla B, Vennström L, Wahlin A, Höglund M, Juliusson G. Lazarevic V, et al. Among authors: uggla b. Eur J Haematol. 2015 May;94(5):419-23. doi: 10.1111/ejh.12446. Epub 2014 Oct 3. Eur J Haematol. 2015. PMID: 25200361
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
Hulegårdh E, Nilsson C, Lazarevic V, Garelius H, Antunovic P, Rangert Derolf Å, Möllgård L, Uggla B, Wennström L, Wahlin A, Höglund M, Juliusson G, Stockelberg D, Lehmann S. Hulegårdh E, et al. Among authors: uggla b. Am J Hematol. 2015 Mar;90(3):208-14. doi: 10.1002/ajh.23908. Epub 2015 Jan 16. Am J Hematol. 2015. PMID: 25421221 Free article.
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
Österroos A, Maia T, Eriksson A, Jädersten M, Lazarevic V, Wennström L, Antunovic P, Cammenga J, Deneberg S, Lorenz F, Möllgård L, Uggla B, Ölander E, Aguiar E, Trigo F, Höglund M, Juliusson G, Lehmann S. Österroos A, et al. Among authors: uggla b. Haematologica. 2022 Jul 1;107(7):1528-1537. doi: 10.3324/haematol.2021.280093. Haematologica. 2022. PMID: 35081688 Free PMC article.
34 results